Feb 26, 2026 06:40PM
Feb 26, 2026 05:55PM
Jan 7, 2026 08:02AM
Dec 31, 2025 03:30PM
Dec 31, 2025 08:42AM
Aug 27, 2025 08:35AM
Aug 25, 2025 07:00AM Xeris receives Orange Book listing for Recorlev patent extending to 2040
Aug 25, 2025 07:00AM
May 8, 2025 07:00AM
Mar 17, 2025 08:03AM
Mar 17, 2025 08:00AM
Feb 24, 2025 08:01AM
Feb 24, 2025 08:00AM
Nov 11, 2024 07:25AM Xeris Pharmaceuticals (XERS) PT Raised to $6.60 at H.C. Wainwright
Aug 8, 2024 07:00AM
Jun 3, 2024 07:00AM
May 30, 2024 07:30AM
May 30, 2024 07:30AM
Jan 10, 2024 09:02AM
Jan 10, 2024 08:00AM
Nov 9, 2023 07:00AM Xeris Biopharma Reports Third Quarter 2023 Financial Results
Aug 8, 2023 07:00AM
Jul 31, 2023 07:04AM
Jul 31, 2023 07:00AM
Mar 30, 2023 07:04AM
Mar 30, 2023 07:00AM
Mar 8, 2023 06:00AM
Feb 2, 2023 07:00AM Xeris Biopharma to Participate in the SVB Securities Global Biopharma Conference 2023
Jan 30, 2023 07:03AM
Jan 30, 2023 07:00AM
Jan 5, 2023 04:03PM
Jan 5, 2023 07:04AM
Jan 5, 2023 07:00AM
Dec 15, 2022 07:05AM
Dec 15, 2022 07:00AM Xeris Biopharma Announces Plans for a Phase II Dose-Finding Study for Its Investigational Subcutaneous (SC) Levothyroxine (XP-8121) as Replacement Therapy for Hypothyroidism
Nov 23, 2022 06:03AM
Nov 23, 2022 06:00AM
Nov 9, 2022 07:00AM
Nov 2, 2022 07:00AM
Nov 1, 2022 07:00AM
Oct 20, 2022 06:40AM
Oct 20, 2022 06:00AM Xeris Biopharma Announces Positive Topline Phase 1 Clinical Data of Its Investigational Subcutaneous (SC) Levothyroxine (XP-8121); Hosts Conference Call and Webcast
Aug 10, 2022 07:00AM
Aug 3, 2022 07:30AM
Aug 1, 2022 07:30AM
Aug 1, 2022 07:30AM
May 12, 2022 04:02PM
May 11, 2022 07:00AM
May 4, 2022 08:00AM Xeris Biopharma to Report First Quarter 2022 Financial Results on May 11, 2022
Mar 16, 2022 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All